Specify a stock or a cryptocurrency in the search bar to get a summary
YS Biopharma Co., Ltd. Ordinary Shares
YSYS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China. Address: Building No. 2, Beijing, China, 102629
Analytics
WallStreet Target Price
4.17 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures YS
Dividend Analytics YS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History YS
Stock Valuation YS
Financials YS
Results | 2019 | Dynamics |